Anxiety disorders among methamphetamine dependent adults: Association with post-treatment functioning

American Journal on Addictions

Volumn 19, Issue 5, 2010, Pages 385-390

  Glasner Edwards, Suzette ^a   Mooney, Larissa J ^a   Marinelli Casey, Patricia ^a   Hillhouse, Maureen ^a   Ang, Alfonso ^b   Rawson, Richard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DEPENDENCE; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOSOCIAL REHABILITATION; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AMPHETAMINE-RELATED DISORDERS; ANXIETY DISORDERS; BEHAVIORAL SYMPTOMS; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77955790588     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2010.00061.x     Document Type: Article

References (32)

1. Zweben JE, Cohen JB, Christian D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004 13 : 181 190.
2. Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008 27 : 253 262.
3. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009 104 : 1085 1099.
4. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction. 2005 100 : 1320 1329.
5. Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 1996 91 : 81 87.
6. McKetin R, Ross J, Kelly E, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev. 2008 27 : 277 285.
7. Conway KP, Compton W, Stinson FS, et al. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006 67 : 247 257.
8. Rounsaville BJ, Kosten TR, Weissman MM, et al. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Arch Gen Psychiatry. 1986 43 : 739 745.
9. Rounsaville BJ, Dolinsky ZS, Babor TF, et al. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry. 1987 44 : 505 513.
10. Verheul R, Van Den Brink W, Hartgers C. Personality disorders predict relapse in alcoholic patients. Addict Behav. 1998 23 : 869 882.
11. McKay JR, Pettinati HM, Morrison R, et al. Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study. Psychol Addict Behav. 2002 16 : 225 235.
12. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, et al. Psychopathology in methamphetamine dependent adults 3 years after treatment. Drug Alcohol Rev. 2010 29 : 12 20.
13. Brown RA, Monti PM, Myers MG, et al. Depression among cocaine abusers in treatment: Relation to cocaine and alcohol use and treatment outcome. Am J Psychiatry. 1998 155 : 220 225.
14. Tate SR, Brown SA, Unrod M, et al. Context of relapse for substance-dependent adults with and without comorbid psychiatric disorders. Addict Behav. 2004 29 : 1707 1724.
15. Rawson RA, Marinelli-Casey P, Anglin MD, et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004 99 : 708 717.
16. Rawson R, Huber A, Brethen P, et al. Methamphetamine and cocaine users: Differences in characteristics and treatment retention. J Psychoactive Drugs. 2000 32 : 233 238.
17. McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980 168 : 26 33.
18. Hillhouse M, Marinelli-Casey P, Rawson R. The LET (Life Experience Timeline): A new instrument for collecting time-anchored natural history data. Poster presented at the 67th annual meeting of the College on Problems of Drug Dependence
19. Nurco DN, Bonito AJ, Lerner M, et al. Studying addicts over time: Methodology and preliminary findings. Am J Drug Alcohol Abuse. 1975 2 : 183 196.
20. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998 59 (Suppl. 20 22 33 quiz 34-57.
21. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 62 : 617 627. (Pubitemid 40973437)
22. Bourdon KH, Rae DS, Locke BZ, et al. Estimating the prevalence of mental disorders in U.S. adults from the Epidemiologic Catchment Area Survey. Public Health Rep. 1992 107 : 663 668.
23. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004 61 : 807 816.
24. Carroll KM, Power ME, Bryant K, et al. One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis. 1993 181 : 71 79.
25. McNamara C, Schumacher JE, Milby JB, et al. Prevalence of nonpsychotic mental disorders does not affect treatment outcome in a homeless cocaine-dependent sample. Am J Drug Alcohol Abuse. 2001 27 : 91 106.
26. Glasner-Edwards S, Marinelli-Casey P, Gonzales R, et al. Depression among methamphetamine users: Association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. J Nerv Mental Dis. 2009 197 : 225 231.
27. Ritsher JB, McKellar JD, Finney JW, et al. Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders. J Stud Alcohol. 2002 63 : 709 715.
28. Diefenbach GJ, Woolley SB, Goethe JW. The association between self-reported anxiety symptoms and suicidality. J Nerv Mental Dis. 2009 197 : 92 97.
29. Sareen J, Houlahan T, Cox BJ, et al. Anxiety disorders associated with suicidal ideation and suicide attempts in the National Comorbidity Survey. J Nerv Ment Dis. 2005 193 : 450 454.
30. Dalton EJ, Cate-Carter TD, Mundo E, et al. Suicide risk in bipolar patients: The role of co-morbid substance use disorders. Bipolar Disord. 2003 5 : 58 61.
31. Schneider B, Georgi K, Weber B, et al. Risk factors for suicide in substance-related disorders. Psychiatr Prax. 2006 33 : 81 87.
32. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, et al. Risk factors for suicide attempts in methamphetamine dependent patients. Am J Addict. 2008 17 : 24 27.